UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 209

Sortiert nach

Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions

Science (American Association for the Advancement of Science), 2012-07, Vol.337 (6091), p.232-236

2012

Volltextzugriff (PDF)

Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors

Chemical reviews, 2017-01, Vol.117 (1), p.38-66

2017

Volltextzugriff (PDF)

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity

Nature communications, 2017-01, Vol.8 (1), p.13958-14, Article 13958

2017

Volltextzugriff (PDF)

Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6470-6479

2016

Volltextzugriff (PDF)

Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations

PLoS computational biology, 2021-11, Vol.17 (11), p.e1009152-e1009152

2021

Volltextzugriff (PDF)

Kinetics for Drug Discovery: an industry-driven effort to target drug residence time

Drug discovery today, 2017-06, Vol.22 (6), p.896-911

2017

Volltextzugriff (PDF)

Structural basis of selective cannabinoid CB2 receptor activation

Nature communications, 2023-03, Vol.14 (1), p.1447-1447, Article 1447

2023

Volltextzugriff (PDF)

Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor

Molecular pharmacology, 2016-05, Vol.89 (5), p.485-491

2016

Volltextzugriff (PDF)

Indanes-Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors

Medicinal research reviews, 2015-11, Vol.35 (6), p.1097-1126

2015

Volltextzugriff (PDF)

The Role of a Sodium Ion Binding Site in the Allosteric Modulation of the A2A Adenosine G Protein-Coupled Receptor

Structure (London), 2013-12, Vol.21 (12), p.2175-2185

2013

Volltextzugriff (PDF)

Cancer‐related somatic mutations alter adenosine A1 receptor pharmacology—A focus on mutations in the loops and C‐terminus

The FASEB journal, 2022-06, Vol.36 (6), p.e22358-n/a

2022

Volltextzugriff (PDF)

MPP + -Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1203

2022

Volltextzugriff (PDF)

Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3698

2024

Volltextzugriff (PDF)

Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition

Scientific reports, 2021-07, Vol.11 (1), p.14171-14171, Article 14171

2021

Volltextzugriff (PDF)

Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions

Molecules (Basel, Switzerland), 2022-07, Vol.27 (15), p.4676

2022

Volltextzugriff (PDF)

Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure–Affinity Relationships

Molecules (Basel, Switzerland), 2022-03, Vol.27 (7), p.2283

2022

Volltextzugriff (PDF)

A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery

Scientific reports, 2021-01, Vol.11 (1), p.1312-14, Article 1312

2021

Volltextzugriff (PDF)

Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors

Scientific reports, 2021-06, Vol.11 (1), p.12290-14, Article 12290

2021

Volltextzugriff (PDF)

Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology

Molecules (Basel, Switzerland), 2022-06, Vol.27 (12), p.3742

2022

Volltextzugriff (PDF)

A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence

Nature communications, 2023-12, Vol.14 (1), p.8039-8039, Article 8039

2023

Volltextzugriff (PDF)

Targeting the CCL2–CCR2 axis for atheroprotection

European heart journal, 2022-05, Vol.43 (19), p.1799-1808

2022

Volltextzugriff (PDF)

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy

Scientific reports, 2017-03, Vol.7 (1), p.52-12, Article 52

2017

Volltextzugriff (PDF)

The Added Value of Assessing Ligand–Receptor Binding Kinetics in Drug Discovery

ACS medicinal chemistry letters, 2016-09, Vol.7 (9), p.819-821

2016

Volltextzugriff (PDF)

Label-free detection of prostaglandin transporter (SLCO2A1) function and inhibition: insights by wound healing and TRACT assays

Frontiers in pharmacology, 2024-05, Vol.15, p.1372109-1372109

2024

Volltextzugriff (PDF)

1 – 25 von 209

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(206)
Buchkapitel
(3)

Sprache

Englisch
(208)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions

Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity

Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength

Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations

Kinetics for Drug Discovery: an industry-driven effort to target drug residence time

Structural basis of selective cannabinoid CB2 receptor activation

Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor

Indanes-Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors

The Role of a Sodium Ion Binding Site in the Allosteric Modulation of the A2A Adenosine G Protein-Coupled Receptor

Cancer‐related somatic mutations alter adenosine A1 receptor pharmacology—A focus on mutations in the loops and C‐terminus

MPP + -Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition

Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities

Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition

An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters

Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions

Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure–Affinity Relationships

A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery

Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors

Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology

A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence

Targeting the CCL2–CCR2 axis for atheroprotection

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy

The Added Value of Assessing Ligand–Receptor Binding Kinetics in Drug Discovery

Label-free detection of prostaglandin transporter (SLCO2A1) function and inhibition: insights by wound healing and TRACT assays

Suchergebnisse filtern